Pharma operator Mylan has completed the acquisition of Meda

Mylan, a pharmaceutical operator which is also present in Romania, announced today that it has completed the settlement with the shareholders of Meda Aktiebolag to tender all their shares to Mylan. The offer was accepted by shareholders holding approximately 94 percent of the total number of shares and votes in Meda, as of July 29, 2016. Upon the completion and settlement of the offer, Mylan acquired each of these shares. The offer was initially announced on February 10 and it was declared unconditional on August 2. The acceptance period expired on July 29 and will not be extended.

“We are very pleased to have received the overwhelming shareholder support required to complete our acquisition of Meda. Mylan continues to differentiate itself among the world’s pharmaceutical companies in terms of our unique profile and growth trajectory. The addition of Meda will only further add to our existing leadership position within our space and continue to create significant value for our shareholders and other stakeholders,” said Mylan chairman, Robert Coury.

“ This transaction also is extremely compelling financially, providing significant accretion to Mylan’s adjusted earnings per share, the opportunity for substantial synergies and further acceleration of our growth. Importantly, I would like to welcome Meda’s talented and dedicated workforce to the Mylan family, and I look forward to their contributions as we strive to deliver better health for a better world,” added Mylan CEO, Heather Bresch.

“With the addition of Meda, Mylan now has six USD 1 billion therapeutic franchises, and through our enhanced scale and expanded commercial capabilities, we see significant opportunities to further distinguish Mylan among our customers and patients. Meda also opens up a number of new opportunities for us, such as significantly expanding our over-the-counter presence into a USD 1 billion business. Additionally, Meda accelerates our expansion in attractive emerging markets, such as China, Southeast Asia, Russia and the Middle East, and provides us opportunities to maximize our efficient, high quality operating platform and broad product portfolio. I too would like to extend a warm welcome to the Meda team and am excited to begin integrating our businesses and bringing together the best from both of our organizations, ”added also the Mylan president, Rajiv Malik.

Georgiana Bendre